SCHEMBL24609967

SCHEMBL24609967

COC1OC(CCO)C(OCc2ccccc2)C(OCc2ccccc2)C1(C)OCc1ccccc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TACR2 P21452 3/20 0.36
▸ SSTR1 P30872 1/20 0.35
▸ SSTR2 P30874 1/20 0.35
▸ SSTR4 P31391 1/20 0.35
▸ SSTR3 P32745 1/20 0.35
▸ SSTR5 P35346 1/20 0.35
▸ BCHE P06276 4/20 0.35
▸ LGALS8 O00214 1/20 0.34
▸ PDPK1 O15530 1/20 0.33
▸ MTOR P42345 1/20 0.33
▸ SLC6A2 P23975 1/20 0.33
▸ PDE4D Q08499 1/20 0.33
▸ PSEN1 P49768 1/20 0.32
▸ PSEN2 P49810 1/20 0.32
▸ APH1B Q8WW43 1/20 0.32
▸ NCSTN Q92542 1/20 0.32
▸ APH1A Q96BI3 1/20 0.32
▸ PSENEN Q9NZ42 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10082717 0.79 SSTR1 (0.39) TACR2SSTR1SSTR2SSTR4SSTR3
SCHEMBL16756862 0.79 SSTR1 (0.39) TACR2SSTR1SSTR2SSTR4SSTR3
SCHEMBL19020173 0.79 SSTR1 (0.39) TACR2SSTR1SSTR2SSTR4SSTR3
SCHEMBL29090061 0.76 TACR2 (0.42) TACR2LGALS8PDPK1MTORSLC6A2
SCHEMBL4284513 0.74 SSTR1 (0.40) TACR2SSTR1SSTR2SSTR4SSTR3
SCHEMBL3629879 0.74 SSTR1 (0.58) SSTR1SSTR2SSTR4SSTR3SSTR5
SCHEMBL8577464 0.74 SSTR1 (0.58) SSTR1SSTR2SSTR4SSTR3SSTR5
SCHEMBL8992056 0.74 SSTR1 (0.58) SSTR1SSTR2SSTR4SSTR3SSTR5
SCHEMBL8992059 0.74 SSTR1 (0.58) SSTR1SSTR2SSTR4SSTR3SSTR5
Alcohol SCHEMBL9191479 0.72 SSTR1 (0.56) SSTR1SSTR2SSTR4SSTR3SSTR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220213135-A1 DERIVATIVES OF GLYCERO-MANNO-HEPTOSE PHOSPHATE AND THEIR USE IN MODULATING AN IMMUNE RESPONSE SHANGHAI YAO YUAN BIOTECHNOLOGY CO LTD (CN) 2022-07-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220213135-A1 DERIVATIVES OF GLYCERO-MANNO-HEPTOSE PHOSPHATE AND THEIR USE IN MODULATING AN IMMUNE RESPONSE GALK1, PGK1, PHKA1 TACR2 4019/4885SSTR1 3689/4885SSTR2 4563/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback